Association of Neighborhood Context, Cognitive Decline, and Cortical Change in an Unimpaired Cohort
- PMID: 33853894
- PMCID: PMC8205478
- DOI: 10.1212/WNL.0000000000011918
Association of Neighborhood Context, Cognitive Decline, and Cortical Change in an Unimpaired Cohort
Abstract
Objective: To test the hypothesis that neighborhood-level disadvantage is associated with longitudinal measures of neurodegeneration and cognitive decline in an unimpaired cohort.
Methods: Longitudinal MRI and cognitive testing data were collected from 601 cognitively unimpaired participants in the Wisconsin Registry for Alzheimer's Prevention Study and the Wisconsin Alzheimer's Disease Research Center clinical cohort. Area Deprivation Index was geospatially determined based on participant residence geocode and ranked relative to state of residence. Linear regression models were fitted to test associations between neighborhood-level disadvantage and longitudinal change in cortical thickness and cognitive test performance. Mediation tests were used to assess whether neurodegeneration and cognitive decline were associated with neighborhood-level disadvantage along the same theoretical causal path.
Results: In our middle- to older-aged study population (mean baseline age 59 years), living in the 20% most disadvantaged neighborhoods (n = 19) relative to state of residence was associated with cortical thinning in Alzheimer signature regions (p = 0.002) and decline in the Preclinical Alzheimer's Disease Cognitive Composite (p = 0.04), particularly the Trail-Making Test, part B (p < 0.001), but not Rey Auditory Verbal Learning Test (p = 0.77) or Story Memory Delayed Recall (p = 0.49) subtests. Associations were attenuated but remained significant after controlling for racial and demographic differences between neighborhood-level disadvantage groups. Cortical thinning partially mediated the association between neighborhood-level disadvantage and cognitive decline.
Conclusions: In this longitudinal study of cognitively unimpaired adults, living in the most highly disadvantaged neighborhoods was associated with accelerated degeneration in Alzheimer signature regions and cognitive decline. This study provides further evidence for neighborhood-level disadvantage as a risk factor for preclinical neurodegeneration and cognitive decline in certain populations. Limitations of the present study, including a small number of participants from highly disadvantaged neighborhoods and a circumscribed geographic setting, should be explored in larger and more diverse study cohorts.
© 2021 American Academy of Neurology.
Figures
Similar articles
-
Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US.JAMA Netw Open. 2023 Aug 1;6(8):e2325325. doi: 10.1001/jamanetworkopen.2023.25325. JAMA Netw Open. 2023. PMID: 37647071 Free PMC article.
-
Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume.JAMA Neurol. 2020 Apr 1;77(4):451-460. doi: 10.1001/jamaneurol.2019.4501. JAMA Neurol. 2020. PMID: 31904767 Free PMC article.
-
Impacts of Kidney Dysfunction and Cerebral Cortical Thinning on Cognitive Change in Elderly Population.J Alzheimers Dis. 2020;76(1):225-236. doi: 10.3233/JAD-200053. J Alzheimers Dis. 2020. PMID: 32444541
-
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.J Clin Psychiatry. 2014 Jun;75(6):652-60. doi: 10.4088/JCP.13m08927. J Clin Psychiatry. 2014. PMID: 24816373 Free PMC article. Review.
-
Association of neighborhood context with offspring risk of preterm birth and low birthweight: A systematic review and meta-analysis of population-based studies.Soc Sci Med. 2016 Mar;153:156-64. doi: 10.1016/j.socscimed.2016.02.014. Epub 2016 Feb 11. Soc Sci Med. 2016. PMID: 26900890 Free PMC article. Review.
Cited by
-
Neighborhood greenspace and neighborhood income associated with white matter grade worsening: Cardiovascular Health Study.Alzheimers Dement (Amst). 2023 Oct 25;15(4):e12484. doi: 10.1002/dad2.12484. eCollection 2023 Oct-Dec. Alzheimers Dement (Amst). 2023. PMID: 37885920 Free PMC article.
-
How does the macroenvironment influence brain and behaviour - a review of current status and future perspectives.medRxiv [Preprint]. 2023 Oct 10:2023.10.09.23296785. doi: 10.1101/2023.10.09.23296785. medRxiv. 2023. PMID: 37873310 Free PMC article. Preprint.
-
Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US.JAMA Netw Open. 2023 Aug 1;6(8):e2325325. doi: 10.1001/jamanetworkopen.2023.25325. JAMA Netw Open. 2023. PMID: 37647071 Free PMC article.
-
Dementia Risk and Disadvantaged Neighborhoods.JAMA Neurol. 2023 Sep 1;80(9):903-909. doi: 10.1001/jamaneurol.2023.2120. JAMA Neurol. 2023. PMID: 37464954
-
Association of neighborhood deprivation with white matter connectome abnormalities in temporal lobe epilepsy.Epilepsia. 2023 Sep;64(9):2484-2498. doi: 10.1111/epi.17702. Epub 2023 Jul 11. Epilepsia. 2023. PMID: 37376741
References
-
- US Department of Health and Human Services. Healthy People 2020: An Opportunity to Address Societal Determinants of Health in the United States. 2010. Available at: healthypeople.gov/2010/hp2020/advisory/SocietalDeterminantsHealth.htm.
-
- World Health Organization. A conceptual framework for action on the social determinants of health: debates, policy & practice, case studies. 2010. Accessed August 9, 2018. Available at: apps.who.int/iris/bitstream/10665/44489/1/9789241500852_eng.pdf.
-
- Turrell G, Lynch JW, Kaplan GA, Everson SA, Helkala E-L. Socioeconomic position across the lifecourse and cognitive function in late middle age. J Gerontol Soc Sci 2002;57B:S43–S51. - PubMed
-
- Sattler C, Toro P, Schönknecht P, Schröder J. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease. Psychiatry Res 2012;196:90–95. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG037639/AG/NIA NIH HHS/United States
- UL1 RR025011/RR/NCRR NIH HHS/United States
- T32 GM008692/GM/NIGMS NIH HHS/United States
- RF1 AG027161/AG/NIA NIH HHS/United States
- UL1 TR002373/TR/NCATS NIH HHS/United States
- P30 AG062715/AG/NIA NIH HHS/United States
- P50 AG033514/AG/NIA NIH HHS/United States
- R01 AG027161/AG/NIA NIH HHS/United States
- R01 MD010243/MD/NIMHD NIH HHS/United States
- F31 AG062116/AG/NIA NIH HHS/United States
- R01 AG021155/AG/NIA NIH HHS/United States
- R56 AG037639/AG/NIA NIH HHS/United States
- RF1 AG057784/AG/NIA NIH HHS/United States
- F30 AG059346/AG/NIA NIH HHS/United States
- R01 AG070883/AG/NIA NIH HHS/United States
- R01 AG054059/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical